Filing Details
- Accession Number:
- 0001209191-19-017631
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-07 13:56:14
- Reporting Period:
- 2019-03-06
- Accepted Time:
- 2019-03-07 13:56:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1524472 | Xylem Inc. | XYL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1421560 | S Claudia Toussaint | C/O Xylem Inc. 1 International Drive Rye Brook NY 10573 | Svp, Gc & Corporate Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-06 | 5,869 | $48.33 | 59,008 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-06 | 5,869 | $76.37 | 53,139 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-03-06 | 2,346 | $76.37 | 50,793 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common | Employee Stock Option | Disposition | 2019-03-06 | 5,869 | $76.37 | 5,869 | $48.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,737 | 2027-02-21 | No | 4 | M | Direct |
Footnotes
- These options were exercised pursuant to a 10b5-1 plan adopted by the reporting person on February 4, 2019
- This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $75.85 to $76.81 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
- The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 4, 2019
- This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $75.91 to $76.81 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
- This grant vests in 3 installments: 5,869 options on February 21, 2018, 5,869 options on February 21, 2019 and 5,868 options on February 21, 2020
Billionaire Hedge Funds
